AI
ABVX

Allostery Investments’s Abivax ABVX Stock Holding History

Allostery Investments’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-167,350
Closed -$1.28M – 1
2025
Q2 		$1.28M Sell
167,350
-932,304
-85% -$6.08M 16.31% 1
2025
Q1 		$6.87M Buy
1,099,654
+508,401
+86% +$3.44M 9.91% 1
2024
Q4 		$4.33M Buy
+591,253
New +$5.44M 4.52% 7

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Allostery Investments's ABVX Position: Q3 2025 in Review

Allostery Investments sold out of Abivax (ABVX) in Q3 2025, closing a stake of 167,350 shares — an estimated $1.28M sold.

Allostery Investments first reported a position in ABVX in Q4 2024 and held it in 3 quarters. The position peaked at $6.87M in Q1 2025. 165 funds tracked by Wall St. Rank hold ABVX as of Q3 2025.

  • Allostery Investments reported no remaining Abivax position as of Q3 2025 after selling out during the quarter.
  • Allostery Investments sold 167,350 Abivax shares in Q3 2025, an estimated $1.28M.
  • Allostery Investments first reported a position in Abivax in Q4 2024 and held it in 3 quarters.
  • Allostery Investments's Abivax position peaked at $6.87M in Q1 2025.
  • 165 funds tracked by Wall St. Rank held Abivax as of Q3 2025.

Based on Allostery Investments's 13F filing for Q3 2025.